克罗恩病上消化道受累的临床特征、治疗需求与演变:CROHNEX研究
基于ENEIDA登记处24 738例克罗恩病患者,识别出4058例上消化道受累(占16%),最终纳入854例病例与1708例对照进行配对分析。上消化道受累独立关联广泛病变、狭窄、慢性缺铁性贫血及二线生物制剂使用,且无狭窄生存期更短。孤立上消化道受累者更常见局限性疾病并接受更多内镜下狭窄扩张。
要点
- 克罗恩病上消化道受累占16%,与广泛病变、狭窄、慢性缺铁性贫血及二线生物制剂使用独立相关。
- 上消化道受累者无狭窄中位时间14年,显著短于对照的21年。
- 孤立上消化道受累者更常见局限性疾病,但接受更多内镜下狭窄扩张。
核心结论
- 克罗恩病上消化道受累与更广泛病变、狭窄、慢性缺铁性贫血及二线生物制剂使用独立相关,且无狭窄生存期更短。
研究设计与样本
- 基于ENEIDA登记处的全国性病例对照研究,病例为上消化道受累(孤立或合并回肠/回结肠受累),对照为回肠/回结肠受累,按诊断年份±2.5年1:2匹配。
- 排除孤立/ predominantly结肠受累或复杂肛瘘患者,最终纳入854例病例和1708例对照。
主要发现
- 上消化道受累独立关联广泛病变(OR 2.7 [2.2-3.3],P < 0.0001)。
- 上消化道受累独立关联狭窄(OR 1.8 [1.5-2.2],P < 0.0001)。
- 上消化道受累独立关联慢性缺铁性贫血(OR 2.2 [1.3-3.2],P < 0.001)。
- 上消化道受累独立关联二线生物制剂使用(OR 1.7 [1.1-2.6],P = 0.021)。
- 病例无狭窄中位时间14年(95% CI 12-16),对照21年(95% CI 19-23),P < 0.0001。
关键数值与推荐
- 孤立上消化道受累相比合并回肠/回结肠受累更常见局限性疾病(OR 0.5 [0.3-0.8],P = 0.003)。
- 孤立上消化道受累接受更多内镜下狭窄扩张(OR 2.7 [1.3-5.4],P = 0.006)。
临床怎么用
- 提高对上消化道受累临床画面和治疗需求的认识,可能有助于早期诊断和治疗上消化道病变。
- 早期干预可能预防诊断时和随访中常见的结构性损伤。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Crohn's disease (CD) with upper gastrointestinal involvement (UGI) may have a more aggressive and refractory course. However, evidence on this phenotype of patients is scarce. AIMS: To identify the clinical characteristics, therapeutic requirements and complications associated with UGI in CD METHODS: Nationwide study of cases (UGI, UGI plus ileal/ileocolonic involvement) paired with controls (ileal/ileocolonic involvement) from the ENEIDA registry. Cases were matched to 2 controls by year of diagnosis ± 2.5 years. Patients with exclusive/predominant colonic location or complex perianal fistula were excluded. RESULTS: Of 24 738 patients with CD in the ENEIDA registry, we identified 4058 with UGI (16% of the total CD cohort). Finally, 854 cases and 1708 controls were included. Cases were independently associated to extensive involvement (OR 2.7 [2.2-3.3], P < 0.0001), strictures [OR 1.8 (1.5-2.2), P < 0.0001], chronic iron deficiency anaemia [OR 2.2 (1.3-3.2), P < 0.001] and use of second-line biologics [OR 1.7 (1.1-2.6), P = 0.021]. The median stricture-free time was 14 years (95% CI, 12-16) for cases vs 21 years (95% CI, 19-23) for controls (P < 0.0001). Cases with isolated UGI compared to UGI plus ileal/ileocolonic more frequently had localised disease [OR 0.5(0.3-0.8), P = 0.003] and underwent more endoscopic stricture dilations [OR 2.7(1.3-5.4), P = 0.006]. CONCLUSIONS: The largest cohort of patients with CD and UGI provides information on the natural history of this particular phenotype. Increased awareness of the clinical picture and therapeutic requirements of these patients could lead to earlier diagnosis and treatment of upper gastrointestinal lesions, preventing the structural damage frequently seen in these patients at diagnosis and during follow-up.
引用
- Sainz E, Zabana Y, Miguel I, et al. Clinical features, therapeutic requirements and evolution of patients with Crohn's disease and upper gastrointestinal involvement (CROHNEX study). Aliment Pharmacol Ther. 2021. PMID: 34406676. doi:10.1111/apt.16547
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。